T he paramyxoviruses comprise a group of enveloped viruses that harbor nonsegmented, negative-sense RNA genomes (1). Included among the paramyxoviruses are a number of human and animal pathogens, including measles virus, mumps virus, Nipah virus, respiratory syncytial virus (RSV), and Newcastle disease virus (NDV). Paramyxovirus infections are spread via particles which bud from plasma membranes of infected cells. Formation of these particles is driven by the viral matrix (M) proteins which can self-assemble to form ordered yet flexible arrays (2, 3) that likely play key roles in generating the membrane curvature required for budding. M proteins also organize the particle assembly process by interacting with the viral glycoproteins via their cytoplasmic tails and also with the viral ribonucleoprotein (vRNP) complexes via the nucleocapsid (N or NP) proteins (reviewed in references 4 and 5). These interactions bring together and concentrate all of the viral structural components onto specific sites underlying infected cell plasma membranes, enabling infectious virions to subsequently bud from these locations.For many paramyxoviruses, expression of M protein in the absence of any other viral components is sufficient to induce the assembly and release of virus-like particles (VLPs) from transfected cells. M proteins of Sendai virus (6, 7), measles virus (8, 9), Nipah virus (10, 11), Hendra virus (12), Newcastle disease virus (13), and human parainfluenza virus 1 (HPIV1) (14) are all capable of directing VLP production and release from transfected cells when expressed alone. In these cases, additional viral components, including the viral glycoproteins and the nucleocapsid-like structures that form upon expression of paramyxovirus N/NP proteins, can be efficiently packaged into the VLPs if they are coexpressed along with the M proteins (4). For other paramyxoviruses, including mumps virus (15) and parainfluenza virus 5 (PIV5) (16), the